Skip to main content

Advertisement

Table 1 Patient characteristics

From: High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer

Characteristic Number of patients (%)
Patients 78 (100.0)
Median age = 63 years (range 41 to 81)  
Gender  
 Male 55 (70.5)
 Female 23 (29.5)
Pathologic type  
 Squamous carcinoma 41 (52.6)
 Adenocarcinoma 29 (37.2)
 Adenosquamous carcinoma 3 (3.8)
 Large cell carcinoma 5 (6.4)
Pathologic differentiation  
 High 5 (6.4)
 Median 50 (64.1)
 Low 23 (29.5)
Clinical Stage*  
 I 20 (25.6)
 II 9 (11.5)
 IIIA 49 (62.9)
Treatment modality - Curative resection  
 Yes 78 (100.0)
 No 0 (0)
Treatment modality - Adjuvant chemotherapy  
 Yes 64 (82.1)
 No 14 (17.9)
Treatment modality - Postoperative radiotherapy  
 Yes 17 (21.8)
 No 61 (78.2)
  1. *According to Union for International Cancer Control/American Joint Committee on Cancer (6th edition) stage system.